Ha habido 50 transacciones internas recientes registradas para Terns Pharmaceuticals, Inc. (TERN), incluyendo 32 compras y 15 ventas. El total de compras internas fue valorado en $14.84M y el total de ventas internas en $1.33M.
Internos destacados con actividad reciente incluyen Kuriakose Emil, Burroughs Amy L., Fellows David A. Las transacciones internas pueden proporcionar información sobre cómo la dirección de la empresa ve la valoración y perspectivas futuras de la acción.
Operaciones de Insiders — TERN
| Fecha |
Nombre |
Cargo |
Tipo de Transacción |
Acciones |
Precio Promedio |
Valor |
Acciones en Propiedad |
| 2026-04-01 |
Kuriakose Emil |
Chief Medical Officer |
Venta Informativa |
942 |
$52.75 |
$49.69K |
105,673 |
| 2026-03-16 |
Burroughs Amy L. |
Chief Executive Officer |
Venta Informativa |
2,770 |
$47.30 |
$131.03K |
288,976 |
| 2026-02-17 |
Burroughs Amy L. |
Chief Executive Officer |
Venta Informativa |
4,083 |
$39.80 |
$162.5K |
288,976 |
| 2026-02-01 |
Fellows David A |
Director |
Concesión de RSU |
2,828 |
$34.60 |
$97.85K |
2,828 |
| 2026-02-01 |
Kindler Jeffrey B |
Director |
Concesión de RSU |
1,697 |
$34.60 |
$58.72K |
1,697 |
| 2026-02-01 |
Turner Heather D |
Director |
Concesión de RSU |
1,697 |
$34.60 |
$58.72K |
1,697 |
| 2026-02-01 |
Azelby Robert |
Director |
Concesión de RSU |
1,697 |
$34.60 |
$58.72K |
1,697 |
| 2026-02-01 |
Tripuraneni Radhika |
Director |
Concesión de RSU |
1,697 |
$34.60 |
$58.72K |
1,697 |
| 2026-02-01 |
Quigley Jill M. |
Director |
Concesión de RSU |
1,697 |
$34.60 |
$58.72K |
1,697 |
| 2026-01-15 |
Burroughs Amy L. |
Chief Executive Officer |
Venta Informativa |
7,521 |
$37.53 |
$282.23K |
288,976 |
| 2026-01-14 |
Gengos Andrew |
Chief Financial Officer |
Concesión de RSU |
68,750 |
- |
- |
101,788 |
| 2026-01-14 |
Burroughs Amy L. |
Chief Executive Officer |
Concesión de RSU |
150,000 |
- |
- |
288,976 |
| 2026-01-14 |
Kuriakose Emil |
Chief Medical Officer |
Concesión de RSU |
56,250 |
- |
- |
106,615 |
| 2026-01-05 |
Burroughs Amy L. |
Chief Executive Officer |
Ejercicio de Opciones (Venta) |
150,000 |
- |
- |
- |
| 2026-01-02 |
Burroughs Amy L. |
Chief Executive Officer |
Ejercicio de Opciones |
21,551 |
$4.64 |
$100K |
60,315 |
| 2026-01-02 |
Kuriakose Emil |
Chief Medical Officer |
Venta Informativa |
955 |
$38.36 |
$36.63K |
50,365 |
| 2025-11-04 |
Quigley Jill M. |
Director |
Venta Informativa |
24,520 |
$18.00 |
$441.36K |
- |
| 2025-10-01 |
Kuriakose Emil |
Chief Medical Officer |
Venta Informativa |
944 |
$7.85 |
$7.41K |
51,520 |
| 2025-07-01 |
Kuriakose Emil |
Chief Medical Officer |
Venta Informativa |
853 |
$4.27 |
$3.64K |
52,464 |
| 2025-06-27 |
Gengos Andrew |
Chief Financial Officer |
Compra Informativa |
5,000 |
$3.93 |
$19.63K |
20,000 |
| 2025-06-25 |
Burroughs Amy L. |
Chief Executive Officer |
Compra Informativa |
23,314 |
$3.87 |
$90.23K |
47,083 |
| 2025-06-16 |
Gengos Andrew |
Chief Financial Officer |
Compra Informativa |
5,000 |
$3.95 |
$19.73K |
15,000 |
| 2025-06-13 |
Gengos Andrew |
Chief Financial Officer |
Compra Informativa |
5,000 |
$3.75 |
$18.75K |
5,000 |
| 2025-06-11 |
Fellows David A |
Director |
Concesión de RSU |
45,000 |
$4.10 |
$184.5K |
45,000 |
| 2025-06-11 |
Kindler Jeffrey B |
Director |
Concesión de RSU |
45,000 |
$4.10 |
$184.5K |
45,000 |
| 2025-06-11 |
Turner Heather D |
Director |
Concesión de RSU |
45,000 |
$4.10 |
$184.5K |
45,000 |
| 2025-06-11 |
Tripuraneni Radhika |
Director |
Concesión de RSU |
45,000 |
$4.10 |
$184.5K |
45,000 |
| 2025-06-11 |
Lu Hongbo |
Director |
Concesión de RSU |
45,000 |
$4.10 |
$184.5K |
45,000 |
| 2025-06-11 |
Quigley Jill M. |
Director |
Concesión de RSU |
45,000 |
$4.10 |
$184.5K |
45,000 |
| 2025-04-01 |
Kuriakose Emil |
Chief Medical Officer |
Venta Informativa |
952 |
$2.49 |
$2.37K |
53,317 |
| 2025-02-24 |
Gengos Andrew |
Officer |
Desconocido |
- |
- |
- |
- |
| 2025-02-24 |
Gengos Andrew |
Chief Financial Officer |
Concesión de RSU |
750,000 |
$3.73 |
$2.8M |
750,000 |
| 2025-02-20 |
Azelby Robert |
Officer |
Desconocido |
- |
- |
- |
- |
| 2025-02-20 |
Azelby Robert |
Director |
Concesión de RSU |
90,000 |
$4.13 |
$371.7K |
90,000 |
| 2025-02-01 |
Fellows David A |
Director |
Concesión de RSU |
18,650 |
$4.46 |
$83.18K |
18,650 |
| 2025-02-01 |
Kindler Jeffrey B |
Director |
Concesión de RSU |
10,657 |
$4.46 |
$47.53K |
10,657 |
| 2025-02-01 |
Tripuraneni Radhika |
Director |
Concesión de RSU |
10,657 |
$4.46 |
$47.53K |
10,657 |
| 2025-02-01 |
Lu Hongbo |
Director |
Concesión de RSU |
10,657 |
$4.46 |
$47.53K |
10,657 |
| 2025-02-01 |
Quigley Jill M. |
Director |
Concesión de RSU |
10,657 |
$4.46 |
$47.53K |
10,657 |
| 2025-02-01 |
Strauss David Eric |
Principal Accounting Officer |
Desconocido |
60,000 |
$6.59 |
$395.4K |
- |
| 2025-01-30 |
Burroughs Amy L. |
Chief Executive Officer |
Concesión de RSU |
1,075,000 |
$4.64 |
$4.99M |
1,075,000 |
| 2025-01-30 |
Kuriakose Emil |
Chief Medical Officer |
Concesión de RSU |
485,000 |
$4.64 |
$2.25M |
485,000 |
| 2025-01-30 |
Jung Melita Sun |
Chief Business Officer |
Concesión de RSU |
325,000 |
$4.64 |
$1.51M |
325,000 |
| 2025-01-06 |
Vignola Mark J. |
Chief Financial Officer |
Venta Informativa |
9,059 |
$5.80 |
$52.5K |
74,752 |
| 2025-01-06 |
Quigley Jill M. |
Director |
Venta Informativa |
8,760 |
$5.79 |
$50.76K |
- |
| 2025-01-02 |
Vignola Mark J. |
Chief Financial Officer |
Venta Informativa |
8,129 |
$5.72 |
$46.52K |
83,811 |
| 2025-01-02 |
Quigley Jill M. |
Director |
Venta Informativa |
6,240 |
$5.72 |
$35.7K |
8,760 |
| 2025-01-02 |
Kuriakose Emil |
Chief Medical Officer |
Venta Informativa |
4,481 |
$5.71 |
$25.61K |
54,269 |
| 2024-12-12 |
Kuriakose Emil |
Chief Medical Officer |
Concesión de RSU |
120,000 |
$6.59 |
$790.8K |
120,000 |
| 2024-12-05 |
Burroughs Amy L. |
Chief Executive Officer |
Compra Informativa |
15,450 |
$7.15 |
$110.47K |
19,099 |
■ Informativa — transacción en mercado abierto (más significativa)
■ No informativa (compra) — premio, ejercicio de opción, conversión
■ No informativa (venta) — retención fiscal, venta de adjudicación
■ Neutral — regalo, fideicomiso, vencimiento
